Alicja Kalinowska-Łyszczarz

Summary

Publications

  1. ncbi Investigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseases
    Alicja Kalinowska
    University of Medical Sciences, Department of Clinical Neuroimmunology by Chair of Neurology, Ul Przybyszewskiego 49, 60 355 Poznan, Poland
    Expert Opin Investig Drugs 17:1267-79. 2008
  2. ncbi NR2 antibodies: risk assessment of transient ischemic attack (TIA)/stroke in patients with history of isolated and multiple cerebrovascular events
    Joseph D Weissman
    DeKalb Medical Center, Decatur, GA, USA
    J Neurol Sci 300:97-102. 2011
  3. ncbi Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing-remitting multiple sclerosis patients
    Alicja Kalinowska-Łyszczarz
    Department of Clinical Neuroimmunology, Poznan University of Medical Sciences, Poland
    J Neurol Sci 300:81-5. 2011
  4. ncbi Immune cell NT-3 expression is associated with brain atrophy in multiple sclerosis patients
    Alicja Kalinowska-Łyszczarz
    Department of Clinical Neuroimmunology, Chair of Neurology, Poznan University of Medical Sciences, Przybyszewskiego 49, 60 355 Poznan, Poland
    J Neuroimmunol 240:109-13. 2011

Collaborators

Detail Information

Publications4

  1. ncbi Investigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseases
    Alicja Kalinowska
    University of Medical Sciences, Department of Clinical Neuroimmunology by Chair of Neurology, Ul Przybyszewskiego 49, 60 355 Poznan, Poland
    Expert Opin Investig Drugs 17:1267-79. 2008
    ..A number of CCR2 antagonists are being developed for treatment of autoimmune diseases by different pharmaceutical and biotechnological companies...
  2. ncbi NR2 antibodies: risk assessment of transient ischemic attack (TIA)/stroke in patients with history of isolated and multiple cerebrovascular events
    Joseph D Weissman
    DeKalb Medical Center, Decatur, GA, USA
    J Neurol Sci 300:97-102. 2011
    ..Predicting stroke using biomarkers would enable clinicians to help prevent stroke or mitigate damage. Several stroke biomarkers have been investigated but none has shown near term predictive value...
  3. ncbi Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing-remitting multiple sclerosis patients
    Alicja Kalinowska-Łyszczarz
    Department of Clinical Neuroimmunology, Poznan University of Medical Sciences, Poland
    J Neurol Sci 300:81-5. 2011
    ..The aim of this study was to investigate the role of specific chemokines involved in B-cell migration (CXCL13) and in the T(H)-17 immune response (IL-17, CCL17, CCL20)...
  4. ncbi Immune cell NT-3 expression is associated with brain atrophy in multiple sclerosis patients
    Alicja Kalinowska-Łyszczarz
    Department of Clinical Neuroimmunology, Chair of Neurology, Poznan University of Medical Sciences, Przybyszewskiego 49, 60 355 Poznan, Poland
    J Neuroimmunol 240:109-13. 2011
    ..Thus, PBMC-derived neurotrophin-3 might exert a direct or indirect neuroprotective effect in MS...